|
gptkbp:instanceOf
|
gptkb:chemical_compound
|
|
gptkbp:appearance
|
white crystalline solid
|
|
gptkbp:aroma
|
odorless
|
|
gptkbp:ATCCode
|
N03AA01
|
|
gptkbp:boilingPoint
|
1435 °C
|
|
gptkbp:CASNumber
|
7758-02-3
|
|
gptkbp:chemicalFormula
|
KBr
|
|
gptkbp:component
|
potassium
bromine
|
|
gptkbp:countryOfOperation
|
worldwide
|
|
gptkbp:density
|
2.75 g/cm³
|
|
gptkbp:discoveredBy
|
gptkb:Jean-Baptiste_Boussingault
|
|
gptkbp:discoveredIn
|
1835
|
|
gptkbp:drugClass
|
sedative
anticonvulsant
|
|
gptkbp:EC_number
|
231-830-3
|
|
gptkbp:flammability
|
non-flammable
|
|
gptkbp:flavor
|
saline, bitter
|
|
gptkbp:GHSClassification
|
Eye Irrit. 2A
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Potassium bromide
|
|
gptkbp:IUPACName
|
gptkb:Potassium_bromide
|
|
gptkbp:LD50
|
3070 mg/kg (oral, rat)
|
|
gptkbp:legalStatus
|
prescription only (in some countries)
|
|
gptkbp:meltingPoint
|
734 °C
|
|
gptkbp:molecularWeight
|
119.002 g/mol
|
|
gptkbp:pH
|
neutral (7) in aqueous solution
|
|
gptkbp:PubChem_CID
|
24447
|
|
gptkbp:refractiveIndex
|
1.567 (20 °C)
|
|
gptkbp:riskFactor
|
H319 (causes serious eye irritation)
|
|
gptkbp:routeOfAdministration
|
oral
intravenous
|
|
gptkbp:sideEffect
|
confusion
nausea
drowsiness
skin rash
bromism
|
|
gptkbp:solubility
|
high
|
|
gptkbp:stable
|
stable under normal conditions
|
|
gptkbp:storageConditions
|
store in a tightly closed container
|
|
gptkbp:structureType
|
ionic compound
|
|
gptkbp:UNNumber
|
UN 1787
|
|
gptkbp:uses
|
gptkb:veterinary_medicine
photography
chemical analysis
infrared spectroscopy (as a matrix)
medicine (anticonvulsant)
|
|
gptkbp:bfsParent
|
gptkb:Ionic_compound
|
|
gptkbp:bfsLayer
|
6
|